MGNI:NASDAQMagnite, Inc. Analysis
Data as of 2026-04-17 - not real-time
$13.64
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Magnite (MGNI) is trading at $13.64, just above its 20‑day ($12.19) and 50‑day ($12.34) moving averages but well below the 200‑day level ($17.63), signaling a short‑term bounce within a longer‑term downtrend. The 14‑day RSI sits at 66, indicating the stock is approaching overbought territory. A bullish MACD histogram (+0.21) and a line above the signal line reinforce the possibility of near‑term upside. Volume has been trending down, suggesting limited buying pressure ahead of the $13.75 resistance zone. The computed beta of 1.56 and a 30‑day volatility of 42% point to a highly volatile, market‑sensitive instrument. Yet the DCF‑derived fair value of $13.95 is only marginally above the current price, implying limited immediate upside from intrinsic valuation alone. Analyst consensus is strongly positive, with a “strong_buy” rating and median price target of $21.50, translating to an implied upside of roughly 58%.
On the fundamentals side, MGNI delivered $714 M in revenue with 5.9% YoY growth and robust profitability—gross margin of 62.7% and operating margin of 25.4%. Net profit margin of 20.3% and ROE of 17% underscore efficient capital utilization. The balance sheet shows $553 M cash offset by $626 M debt, yielding a debt‑to‑equity of 68%, a leverage level that warrants monitoring. A trailing P/E of 14.4 is well below the industry average of 19.2, positioning the stock as relatively undervalued on a value basis. No dividend is paid, so income‑focused investors should look elsewhere. The company’s focus on programmatic CTV and AI‑driven ad automation aligns with secular digital‑advertising trends, offering a growth catalyst beyond the current earnings pace. In sum, while short‑term price action may be constrained by technical resistance, the combination of solid margins, attractive valuation multiples, and a bullish analyst outlook supports a buy stance for medium‑ to long‑term horizons.
On the fundamentals side, MGNI delivered $714 M in revenue with 5.9% YoY growth and robust profitability—gross margin of 62.7% and operating margin of 25.4%. Net profit margin of 20.3% and ROE of 17% underscore efficient capital utilization. The balance sheet shows $553 M cash offset by $626 M debt, yielding a debt‑to‑equity of 68%, a leverage level that warrants monitoring. A trailing P/E of 14.4 is well below the industry average of 19.2, positioning the stock as relatively undervalued on a value basis. No dividend is paid, so income‑focused investors should look elsewhere. The company’s focus on programmatic CTV and AI‑driven ad automation aligns with secular digital‑advertising trends, offering a growth catalyst beyond the current earnings pace. In sum, while short‑term price action may be constrained by technical resistance, the combination of solid margins, attractive valuation multiples, and a bullish analyst outlook supports a buy stance for medium‑ to long‑term horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD but price near resistance at $13.75
- RSI approaching overbought levels
- Decreasing volume indicating limited short‑term buying pressure
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued P/E relative to industry peers
- Strong profit margins and cash generation
- Analyst median target of $21.50 implying substantial upside
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Secular growth in programmatic and CTV advertising
- AI‑driven platform positioning as a competitive advantage
- Solid balance sheet with ample cash despite moderate leverage
Key Metrics & Analysis
Financial Health
Revenue Growth5.90%
Profit Margin20.26%
P/E Ratio14.4
ROE17.11%
ROA2.03%
Debt/Equity67.91
P/B Ratio2.1
Op. Cash Flow$236.2M
Free Cash Flow$119.6M
Industry P/E19.2
Technical Analysis
TrendBearish
RSI66.0
Support$11.36
Resistance$13.75
MA 20$12.18
MA 50$12.34
MA 200$17.63
MACDBullish
VolumeDecreasing
Fear & Greed Index89.39
Valuation
Fair Value$13.95
Target Price$22.07
Upside/Downside61.81%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.56
Volatility42.00%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.